Skip to main content
Figure 2 | BMC Cardiovascular Disorders

Figure 2

From: Impact of the introduction of drug eluting stents on clinical outcomes in patients undergoing percutaneous and surgical coronary artery revascularisation procedures in Western Australia

Figure 2

Cox adjusted survival curves by year 2000-2004 showing the one-year outcome of MACE (major adverse cardiac events) in the revascularisation cohort (A-C).‚ÄČThe adjusting variables were age, gender, Charlson comorbidity score, principal diagnosis at index admission, type of index admission (emergency, booked), type of hospital at index admission, number of vessels treated (single, multiple), and type of CARP (for the All CARP models only).

Back to article page